Calcification of the heart: mechanisms and therapeutic avenues

References

• Budoff MJ, Achenbach S, Blumenthal RS, et al. Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the american heart association committee on cardiovascular imaging and intervention, council on cardiovascular radiology and intervention, and committee on cardiac imaging, council on clinical cardiology. Circulation. 2006 Oct 17;114:1761–1791.
   PubMed Web of Science ®Google Scholar
• Itagaki MW, Suh RD, Goldin JG. Cardiac CT research: exponential growth. Radiology. 2009;252:468–476. PubMed PMID: 19703884;.
   PubMed Web of Science ®Google Scholar
• McClelland RL, Chung H, Detrano R, et al. Distribution of coronary artery calcium by race, gender, and age: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. 2006 Jan 3;113:30–37. PubMed PMID: 16365194; eng.
   PubMed Web of Science ®Google Scholar
• Bild DE, Detrano R, Peterson D, et al. Ethnic differences in coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. 2005 Mar 15;111:1313–1320. PubMed PMID: 15769774; eng.
   PubMed Web of Science ®Google Scholar
• Ahmed HM, Blaha MJ, Nasir K, et al. Low-risk lifestyle, coronary calcium, cardiovascular events, and mortality: results from MESA. Am J Epidemiol. 2013 Jul;178(1):12–21. PubMed PMID: 23733562; PubMed Central PMCID: PMCPMC3698994. eng.
   PubMed Web of Science ®Google Scholar
• Otsuka F, Sakakura K, Yahagi K, et al. Has our understanding of calcification in human coronary atherosclerosis progressed? Arterioscler Thromb Vasc Biol. 2014;34:724–736.
   PubMed Web of Science ®Google Scholar
• Agatston AS, Janowitz WR, Hildner FJ, et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990 Mar 15;15:827–832. PubMed PMID: 2407762; eng.
   PubMed Web of Science ®Google Scholar
• Mao SS, Pal RS, McKay CR, et al. Comparison of coronary artery calcium scores between electron beam computed tomography and 64-multidetector computed tomographic scanner. J Comput Assist Tomogr. 2009 Mar-Apr;33:175–178. PubMed PMID: 19346841; eng.
   PubMed Web of Science ®Google Scholar
• Nezarat N, Kim M, Budoff M. Role of coronary calcium for risk stratification and prognostication. 10.1007/s11936-017-0509-7. PubMed PMID: 28275938; eng. Curr Treat Options Cardiovasc Med. 2017 Feb;19:8
   PubMedGoogle Scholar
• Howell SJ, Bui J, Thevakumar B, et al. Utility of physician selection of cardiac tests in a chest pain unit to exclude acute coronary syndrome among patients without a history of coronary artery disease. Am J Cardiol. 2018 Apr 1;121:825–829. PubMed PMID: 29452690; eng.
   PubMed Web of Science ®Google Scholar
• Litt HI, Gatsonis C, Snyder B, et al. CT angiography for safe discharge of patients with possible acute coronary syndromes. N Engl J Med. 2012 Apr 12;366:1393–1403. PubMed PMID: 22449295; eng.
   PubMed Web of Science ®Google Scholar
• Hoffmann U, Truong QA, Schoenfeld DA, et al. Coronary CT angiography versus standard evaluation in acute chest pain. New England J Med. 2012;367:299–308. PubMed PMID: 22830462.
   PubMed Web of Science ®Google Scholar
• Matthews SD, Frishman WH. A review of the clinical utility of intravascular ultrasound and optical coherence tomography in the assessment and treatment of coronary artery disease. Cardiol Rev. 2017 Mar/Apr;25:68–76. PubMed PMID: 28099219; eng.
   PubMed Web of Science ®Google Scholar
• Ceponiene I, Nakanishi R, Osawa K, et al. Coronary artery calcium progression is associated with coronary plaque volume progression: results from a quantitative semiautomated coronary artery plaque analysis. JACC Cardiovasc Imaging. 2017 Oct 14 PubMed PMID: 29055625; eng. DOI:10.1016/j.jcmg.2017.07.023.
   PubMed Web of Science ®Google Scholar
• Ahmadi A, Leipsic J, Blankstein R, et al. Do plaques rapidly progress prior to myocardial infarction? The interplay between plaque vulnerability and progression. Circ Res. 2015 Jun 19;117:99–104. PubMed PMID: 26089367.
   PubMed Web of Science ®Google Scholar
• Voros S, Rinehart S, Vazquez-Figueroa JG, et al. Prospective, head-to-head comparison of quantitative coronary angiography, quantitative computed tomography angiography, and intravascular ultrasound for the prediction of hemodynamic significance in intermediate and severe lesions, using fractional flow reserve as reference standard (from the ATLANTA I and II study). Am J Cardiol. 2014 Jan;113(1):23–29. PubMed PMID: 24238960; PubMed Central PMCID: PMCPMC4007350.
   PubMed Web of Science ®Google Scholar
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial.The Lancet.2002 Jul06;360:7–22.
   PubMed Web of Science ®Google Scholar
• Arad Y, Spadaro LA, Roth M, et al. Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: the St. Francis heart study randomized clinical trial. J Am Coll Cardiol. 2005 Jul 5;46:166–172. PubMed PMID: 15992652.
   PubMed Web of Science ®Google Scholar
• Nasir K, Bittencourt MS, Blaha MJ, et al. Implications of coronary artery calcium testing among statin candidates according to american college of cardiology/american heart association cholesterol management guidelines: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol. 2015;66:1657–1668.
   PubMed Web of Science ®Google Scholar
• Sarwar A, Shaw LJ, Shapiro MD, et al. Diagnostic and prognostic value of absence of coronary artery calcification. JACC Cardiovasc Imaging. 2009 Jun;2:675–688. PubMed PMID: 19520336; eng.
   PubMed Web of Science ®Google Scholar
• Kiramijyan S, Ahmadi N, Isma’eel H, et al. Impact of coronary artery calcium progression and statin therapy on clinical outcome in subjects with and without diabetes mellitus. Am J Cardiol. 2013 Feb 1;111:356–361. PubMed PMID: 23206921; eng.
   PubMed Web of Science ®Google Scholar
• Budoff MJ, Yu D, Nasir K, et al. Diabetes and progression of coronary calcium under the influence of statin therapy. Am Heart J. 2005;149:695–700.
   PubMed Web of Science ®Google Scholar
• Rijlaarsdam-Hermsen D, Kuijpers D, van Dijkman PR. Diagnostic and prognostic value of absence of coronary artery calcification in patients with stable chest symptoms. Netherlands Heart Journal: Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation. 2011 May;19:223–228. PubMed PMID: 21541836; PubMed Central PMCID: PMCPMC3087026. eng.
   PubMed Web of Science ®Google Scholar
• Blaha M, Budoff MJ, Shaw LJ, et al. Absence of coronary artery calcification and all-cause mortality. JACC: Cardiovascular Imaging. 2009;2:692–700. 2009 Jun 01.
   PubMed Web of Science ®Google Scholar
• Budoff MJ, McClelland RL, Nasir K, et al. Cardiovascular events with absent or minimal coronary calcification: the multi-ethnic study of Atherosclerosis (MESA). Am Heart J. 2009;158:554–561.
   PubMed Web of Science ®Google Scholar
• McEvoy JW, Blaha MJ, Defilippis AP, et al. Coronary artery calcium progression: an important clinical measurement? A review of published reports. J Am Coll Cardiol. 2010 Nov 9;56:1613–1622. PubMed PMID: 21050970; eng.
   PubMed Web of Science ®Google Scholar
• Zeb I, Li D, Nasir K, et al. Effect of statin treatment on coronary plaque progression - a serial coronary CT angiography study. Atherosclerosis. 2013 Dec;231:198–204. PubMed PMID: 24267226; eng.
   PubMed Web of Science ®Google Scholar
• Thanassoulis G. Lipoprotein (a) in calcific aortic valve disease: from genomics to novel drug target for aortic stenosis. J Lipid Res. 2016 Jun;57:917–924. PubMed PMID: 26685327; PubMed Central PMCID: PMCPMC4878194. eng.
   PubMed Web of Science ®Google Scholar
• Dweck MR, Khaw HJ, Sng GK, et al. Aortic stenosis, atherosclerosis, and skeletal bone: is there a common link with calcification and inflammation? Eur Heart J. 2013 Jun;34:1567–1574. PubMed PMID: 23391586; eng.
   PubMed Web of Science ®Google Scholar
• Bach DS. Prevalence and characteristics of unoperated patients with severe aortic stenosis. PubMed PMID: 21714418; eng. J Heart Valve Dis. 2011 May;20:284–291
   PubMed Web of Science ®Google Scholar
• Grover FL, Vemulapalli S, Carroll JD, et al. 2016 annual report of the society of thoracic surgeons/american college of cardiology transcatheter valve therapy registry. J Am Coll Cardiol. 2017 Mar;14(69):1215–1230. PubMed PMID: 27956264; eng.
   PubMed Web of Science ®Google Scholar
• Teo KK, Corsi DJ, Tam JW, et al. Lipid lowering on progression of mild to moderate aortic stenosis: meta-analysis of the randomized placebo-controlled clinical trials on 2344 patients. Can J Cardiol. 2011;27:800–808.
   PubMed Web of Science ®Google Scholar
• Cowell SJ, Newby DE, Prescott RJ, et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. New England J Med. 2005;352:2389–2397. PubMed PMID: 15944423.
   PubMed Web of Science ®Google Scholar
• Rossebø AB, Pedersen TR, Boman K, et al. Intensive lipid lowering with Simvastatin and Ezetimibe in Aortic stenosis. New England J Med. 2008;359:1343–1356. PubMed PMID: 18765433.
   PubMed Web of Science ®Google Scholar
• Dimitrow PP, Jawien M, Gackowski A. The influence of statins on levels of calcification biomarkers in patients with aortic sclerosis or mild aortic stenosis. PubMed PMID: 21404893; eng. J Heart Valve Dis. 2011 Jan;20:18–22
   PubMed Web of Science ®Google Scholar
• Stewart BF, Siscovick D, Lind BK, et al. Clinical Factors associated with calcific aortic valve disease fn1fn1This study was supported in part by contracts NO1-HC85079 through HC-850086 from the national heart, lung, and blood institute, national institutes of health, Bethesda, Maryland. J Am Coll Cardiol. 1997;29:630–634.
   PubMed Web of Science ®Google Scholar
• Smith J, Luk K, Schulz C, et al. Association of low-density lipoprotein cholesterol–related genetic variants with aortic valve calcium and incident aortic stenosis. JAMA. 2014;312:1764–1771.
   PubMed Web of Science ®Google Scholar
• Owens DS, Katz R, Johnson E, et al. Interaction of age with lipoproteins as predictors of aortic valve calcification in the multi-ethnic study of atherosclerosis. Arch Intern Med. 2008;168:1200–1207.
   PubMedGoogle Scholar
• Mohty D, Pibarot P, Després J-P, et al. Association between plasma LDL particle size, valvular accumulation of oxidized LDL, and inflammation in patients with aortic stenosis. Arterioscler Thromb Vasc Biol. 2008 Jan;28:187–193. PubMed PMID: 17975118; eng.
   PubMed Web of Science ®Google Scholar
• Nordestgaard BG, Chapman MJ, Ray K, et al. Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J. 2010;31:2844–2853. 10 2106 11received08/17/revised 09/24/accepted.
   PubMed Web of Science ®Google Scholar
• Berg K. A NEW SERUM TYPE SYSTEM IN MAN—THE Lp SYSTEM. Acta Pathologica Microbiologica Scandinavica. 1963;59:369–382.
   PubMedGoogle Scholar
• Clarke R, Peden JF, Hopewell JC, et al. Genetic Variants Associated with Lp(a) Lipoprotein level and coronary disease. New England J Med. 2009;361:2518–2528. PubMed PMID: 20032323.
   PubMed Web of Science ®Google Scholar
• Members ATF, Piepoli MF, Hoes AW, et al. European Guidelines on cardiovascular disease prevention in clinical practice:developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur J Prev Cardiol. 2016;23:NP1–NP96.
   PubMed Web of Science ®Google Scholar
• Thanassoulis G, Campbell CY, Owens DS, et al. Genetic associations with valvular calcification and aortic stenosis. New England J Med. 2013;368:503–512. PubMed PMID: 23388002.
   PubMed Web of Science ®Google Scholar
• Rajamannan NM. Osteocardiology: defining the Go/No-Go Time Point for Therapy. Cardiology. 2018;139:175–183. PubMed PMID: 29393145; eng.
   PubMed Web of Science ®Google Scholar
• Moutzouri E, Liberopoulos EN, Tellis CC, et al. Comparison of the effect of simvastatin versus simvastatin/ezetimibe versus rosuvastatin on markers of inflammation and oxidative stress in subjects with hypercholesterolemia. Atherosclerosis. 2013 Nov;231:8–14. PubMed PMID: 24125402; eng.
   PubMed Web of Science ®Google Scholar
• Carlson LA, Hamsten A, Asplund A. Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acid. PubMed PMID: 2530298; eng. J Intern Med. 1989 Oct;226:271–276
   PubMed Web of Science ®Google Scholar
• Goldberg A, Alagona P Jr., Capuzzi DM, et al. Multiple-dose efficacy and safety of an extended-release form of niacin in the management of hyperlipidemia. Am J Cardiol. 2000 May 1;85:1100–1105. PubMed PMID: 10781759; eng.
   PubMed Web of Science ®Google Scholar
• Chapman MJ, Redfern JS, McGovern ME, et al. Niacin and fibrates in atherogenic dyslipidemia: pharmacotherapy to reduce cardiovascular risk. Pharmacol Ther. 2010 Jun;126:314–345. PubMed PMID: 20153365; eng.
   PubMed Web of Science ®Google Scholar
• Bruckert E, Labreuche J, Amarenco P. Meta-analysis of the effect of nicotinic acid alone or in combination on cardiovascular events and atherosclerosis. . Atherosclerosis. 2010 Jun;210:353–361. PubMed PMID: 20079494; eng.
   PubMed Web of Science ®Google Scholar
• Cohen JC, Boerwinkle E, Mosley TH Jr., et al. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med. 2006 Mar 23;354:1264–1272.
   PubMed Web of Science ®Google Scholar
• Abramowitz Y, Jilaihawi H, Chakravarty T, et al. Mitral annulus calcification. J Am Coll Cardiol. 2015 Oct 27;66:1934–1941. PubMed PMID: 26493666; eng.
   PubMed Web of Science ®Google Scholar
• Kanjanauthai S, Nasir K, Katz R, et al. Relationships of mitral annular calcification to cardiovascular risk factors: the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis. 2010 Dec;213:558–562. PubMed PMID: 20926076; PubMed Central PMCID: PMCPMC2997868. eng.
   PubMed Web of Science ®Google Scholar
• Correia J, Rodrigues D, da Silva AM, et al. Massive calcification of the mitral valve annulus in an adolescent with Marfan syndrome. A case report. Revista Portuguesa De Cardiologia: Orgao Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology: an Official Journal of the Portuguese Society of Cardiology. 2006 Oct;25:921–926. PubMed PMID: 17190241; eng por.
   PubMedGoogle Scholar
• Schieken RM, Kerber RE, Ionasescu VV, et al. Cardiac manifestations of the mucopolysaccharidoses. Circulation. 1975 Oct;52:700–705. PubMed PMID: 808361; eng.
   PubMed Web of Science ®Google Scholar
• Silbiger JJ. Anatomy, mechanics, and pathophysiology of the mitral annulus. Am Heart J. 2012 Aug;164:163–176. PubMed PMID: 22877801; eng.
   PubMed Web of Science ®Google Scholar
• Benjamin EJ, Plehn JF, D’Agostino RB, et al. Mitral annular calcification and the risk of stroke in an elderly cohort. N Engl J Med. 1992 Aug;327(6):374–379. PubMed PMID: 1625711; eng.
   PubMed Web of Science ®Google Scholar
• Boon A, Lodder J, Cheriex E, et al. Mitral annulus calcification is not an independent risk factor for stroke: a cohort study of 657 patients. J Neurol. 1997 Sep;244:535–541. PubMed PMID: 9352449; eng.
   PubMed Web of Science ®Google Scholar
• Allison MA, Cheung P, Criqui MH, et al. Mitral and aortic annular calcification are highly associated with systemic calcified atherosclerosis. Circulation. 2006 Feb 14;113:861–866. PubMed PMID: 16461818; eng.
   PubMed Web of Science ®Google Scholar
• Budoff MJ, Katz R, Wong ND, et al. Effect of scanner type on the reproducibility of extracoronary measures of calcification: the multi-ethnic study of atherosclerosis. Acad Radiol. 2007;14:1043–1049.
   PubMed Web of Science ®Google Scholar
• Lerner RG, Aronow WS, Sekhri A, et al. Warfarin use and the risk of valvular calcification. Journal of Thrombosis and Haemostasis: JTH. 2009 Dec;7:2023–2027. PubMed PMID: 19793187; eng.
   PubMed Web of Science ®Google Scholar
• Rennenberg RJ, van Varik BJ, Schurgers LJ, et al. Chronic coumarin treatment is associated with increased extracoronary arterial calcification in humans. Blood. 2010 Jun 17;115:5121–5123. PubMed PMID: 20354170; eng.
   PubMed Web of Science ®Google Scholar
• Koos R, Mahnken AH, Muhlenbruch G, et al. Relation of oral anticoagulation to cardiac valvular and coronary calcium assessed by multislice spiral computed tomography. Am J Cardiol. 2005 Sep 15;96:747–749. PubMed PMID: 16169351; eng.
   PubMed Web of Science ®Google Scholar
• Shea MK, Cj O, Hoffmann U, et al. Vitamin K supplementation and progression of coronary artery calcium in older men and women. Am J Clin Nutr. 2009 Jun;89:1799–1807. PubMed PMID: 19386744; PubMed Central PMCID: PMCPMC2682995. eng.
   PubMed Web of Science ®Google Scholar
• Granger CB, Alexander JH, Jjv M, et al. Apixaban versus warfarin in patients with atrial fibrillation. New England J Med. 2011;365:981–992. PubMed PMID: 21870978.
   PubMed Web of Science ®Google Scholar
• Zhou Q, Bea F, Preusch M, et al. Evaluation of plaque stability of advanced atherosclerotic lesions in apo E-deficient mice after treatment with the oral factor Xa inhibitor rivaroxaban. Mediators Inflamm. 2011;2011:432080. PubMed PMID: 21772662; PubMed Central PMCID: PMCPMC3134269. eng.
   PubMed Web of Science ®Google Scholar
• Hara T, Fukuda D, Tanaka K, et al. Rivaroxaban, a novel oral anticoagulant, attenuates atherosclerotic plaque progression and destabilization in ApoE-deficient mice. Atherosclerosis. 2015 Oct;242:639–646. PubMed PMID: 25817329; eng.
   PubMed Web of Science ®Google Scholar
• Osawa K, Nakanishi R, Win TT, et al. Rationale and design of a randomized trial of apixaban vs warfarin to evaluate atherosclerotic calcification and vulnerable plaque progression. Clin Cardiol. 2017 Oct;40:807–813. PubMed PMID: 28703931; eng.
   PubMed Web of Science ®Google Scholar
• Win TT, Nakanishi R, Osawa K, et al. Abstract 16238: apixaban versus warfarin in the evaluation of progression of atherosclerotic calcification and vulnerable plaque (A Prospective Randomized Trial). Circulation. 2017;136:A16238–A16238.
   Web of Science ®Google Scholar
• Budoff MJ, Hokanson JE, Nasir K, et al. Progression of coronary artery calcium predicts all-cause mortality. JACC Cardiovasc Imaging. 2010 Dec;3:1229–1236. PubMed PMID: 21163451; eng.
   PubMed Web of Science ®Google Scholar
• Holden RM, Booth SL, Day AG, et al. Inhibiting the progression of arterial calcification with vitamin K in HemoDialysis patients (iPACK-HD) trial: rationale and study design for a randomized trial of vitamin K in patients with end stage kidney disease. Canadian J Kidney Health Disease. 2015;2:17. PubMed PMID: 26075081; PubMed Central PMCID: PMCPMC4465015. eng.
   PubMedGoogle Scholar
• Block GA, Raggi P, Bellasi A, et al. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int. 2007;71:438–441.
   PubMed Web of Science ®Google Scholar
• Budoff MJ, Rader DJ, Reilly MP, et al. Relationship of estimated GFR and coronary artery calcification in the CRIC (Chronic Renal Insufficiency Cohort) Study. American Journal Kidney Diseases: Official Journal National Kidney Foundation. 2011 Oct;58:519–526. PubMed PMID: 21783289; PubMed Central PMCID: PMCPMC3183168. eng.
   PubMed Web of Science ®Google Scholar
• Weiner DE, Tighiouart H, Amin MG, et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrology: JASN. 2004 May;15:1307–1315. PubMed PMID: 15100371; eng.
   PubMed Web of Science ®Google Scholar
• Li X, Giachelli CM. Sodium-dependent phosphate cotransporters and vascular calcification. Curr Opin Nephrol Hypertens. 2007 Jul;16:325–328. PubMed PMID: 17565274; eng.
   PubMed Web of Science ®Google Scholar
• Shantouf R, Ahmadi N, Flores F, et al. Impact of phosphate binder type on coronary artery calcification in hemodialysis patients. Clin Nephrol. 2010 Jul;74:12–18. PubMed PMID: 20557861; eng.
   PubMed Web of Science ®Google Scholar
• Qunibi W, Moustafa M, Lr M, et al. A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study. American Journal Kidney Diseases: Official Journal National Kidney Foundation. 2008 Jun;51:952–965. PubMed PMID: 18423809; eng.
   PubMed Web of Science ®Google Scholar
• Wang C, Liu X, Zhou Y, et al. New conclusions regarding comparison of sevelamer and calcium-based phosphate binders in coronary-artery calcification for dialysis patients: a meta-analysis of randomized controlled trials. PloS One. 2015;10:e0133938. PubMed PMID: 26230677; PubMed Central PMCID: PMCPMC4521824. eng.
   PubMed Web of Science ®Google Scholar
• Pilkey RM, Morton AR, Boffa MB, et al. Subclinical vitamin K deficiency in hemodialysis patients. American Journal Kidney Diseases: Official Journal National Kidney Foundation. 2007 Mar;49:432–439. PubMed PMID: 17336705; eng.
   PubMed Web of Science ®Google Scholar
• Holden RM, Morton AR, Garland JS, et al. Vitamins K and D status in stages 3-5 chronic kidney disease. Clin Journal Am Soc Nephrology: CJASN. 2010 Apr;5:590–597. PubMed PMID: 20167683; PubMed Central PMCID: PMCPMC2849681. eng.
   PubMed Web of Science ®Google Scholar
• Holden RM, Sanfilippo AS, Hopman WM, et al. Warfarin and aortic valve calcification in hemodialysis patients. J Nephrol. 2007 Jul-Aug;20:417–422. PubMed PMID: 17879207; eng.
   PubMed Web of Science ®Google Scholar
• Capewell S, Beaglehole R, Seddon M, et al. Explanation for the decline in coronary heart disease mortality rates in Auckland, New Zealand, between 1982 and 1993. Circulation. 2000;102:1511–1516.
   PubMed Web of Science ®Google Scholar
• Zeng T, Zhang CL, Zhao XL, et al. The roles of garlic on the lipid parameters: a systematic review of the literature. Crit Rev Food Sci Nutr. 2013;53:215–230. PubMed PMID: 23215996; eng.
   PubMed Web of Science ®Google Scholar
• Gorinstein S, Jastrzebski Z, Namiesnik J, et al. The atherosclerotic heart disease and protecting properties of garlic: contemporary data. Mol Nutr Food Res. 2007 Nov;51:1365–1381. PubMed PMID: 17966138; eng.
   PubMed Web of Science ®Google Scholar
• Svechnikov VA. [Mechanism of action of garlic on the heart and on the blood vessels]. Tr Leningr Sanitarnogig Med Inst. 1957;34: 189–192. PubMed PMID: 13468071; rus.
   PubMedGoogle Scholar
• Stabler SN, Tejani AM, Huynh F, et al. Garlic for the prevention of cardiovascular morbidity and mortality in hypertensive patients. The Cochrane Database of Systematic Reviews. 2012 Aug 15:Cd007653. PubMed PMID: 22895963; eng. DOI: 10.1002/14651858.CD007653.pub2
   PubMed Web of Science ®Google Scholar
• Khatua TN, Adela R, Banerjee SK. Garlic and cardioprotection: insights into the molecular mechanisms. Can J Physiol Pharmacol. 2013 Jun;91:448–458. PubMed PMID: 23746107; eng.
   PubMed Web of Science ®Google Scholar
• Varshney R, Budoff MJ. Garlic and heart disease1–3. J Nutr. 2016;146:416S–421S.
   PubMed Web of Science ®Google Scholar
• Budoff MJ, Takasu J, Flores FR, et al. Inhibiting progression of coronary calcification using aged garlic extract in patients receiving statin therapy: a preliminary study. Prev Med. 2004 Nov;39:985–991. PubMed PMID: 15475033; eng.
   PubMed Web of Science ®Google Scholar
• Budoff MJ, Ahmadi N, Gul KM, et al. Aged garlic extract supplemented with B vitamins, folic acid and L-arginine retards the progression of subclinical atherosclerosis: a randomized clinical trial. Prev Med. 2009 Aug-Sep;49:101–107. PubMed PMID: 19573556; eng.
   PubMed Web of Science ®Google Scholar
• Zeb I, Ahmadi N, Nasir K, et al. Aged garlic extract and coenzyme Q10 have favorable effect on inflammatory markers and coronary atherosclerosis progression: a randomized clinical trial. J Cardiovasc Dis Res. 2012 Jul 3:185–190. PubMed PMID: 22923934; PubMed Central PMCID: PMCPMC3425023. eng. DOI: 10.4103/0975-3583.98883
   PubMedGoogle Scholar
• Matsumoto S, Nakanishi R, Li D, et al. Aged garlic extract reduces low attenuation plaque in coronary arteries of patients with metabolic syndrome in a prospective randomized double-blind study. J Nutr. 2016 Feb;146:427s–432s. PubMed PMID: 26764322; eng.
   PubMed Web of Science ®Google Scholar
• Krauss RM, Eckel RH, Howard B, et al. AHA dietary guidelines: revision 2000: a statement for healthcare professionals from the nutrition committee of the american heart association. Circulation. 2000 Oct 31;102:2284–2299. PubMed PMID: 11056107; eng.
   PubMed Web of Science ®Google Scholar
• Siscovick DS, Barringer TA, Fretts AM, et al. Omega-3 Polyunsaturated Fatty Acid (Fish Oil) supplementation and the prevention of clinical cardiovascular disease: a science advisory from the american heart association. Circulation. 2017 Apr 11;135:e867–e884. PubMed PMID: 28289069; eng.
   PubMed Web of Science ®Google Scholar
• He K, Liu K, Daviglus ML, et al. Intakes of long-chain n-3 polyunsaturated fatty acids and fish in relation to measurements of subclinical atherosclerosis. Am J Clin Nutr. 2008 Oct;88:1111–1118. PubMed PMID: 18842801; PubMed Central PMCID: PMCPMC4151325. eng.
   PubMed Web of Science ®Google Scholar
• Ueeda M, Doumei T, Takaya Y, et al. Serum N-3 polyunsaturated fatty acid levels correlate with the extent of coronary plaques and calcifications in patients with acute myocardial infarction. Circ Journal: Official Journal Jpn Circ Soc. 2008 Nov;72:1836–1843. PubMed PMID: 18812674; eng.
   PubMed Web of Science ®Google Scholar
• Sekikawa A, Miura K, Lee S, et al. Long chain n-3 polyunsaturated fatty acids and incidence rate of coronary artery calcification in Japanese men in Japan and white men in the USA: population based prospective cohort study. Heart (British Cardiac Society). 2014 Apr;100:569–573. PubMed PMID: 24352736; PubMed Central PMCID: PMCPMC3949146. eng.
   PubMed Web of Science ®Google Scholar
• Budoff M, Brent Muhlestein J, Le VT, et al. Effect of Vascepa (icosapent ethyl) on progression of coronary atherosclerosis in patients with elevated triglycerides (200-499 mg/dL) on statin therapy: rationale and design of the EVAPORATE study. Clin Cardiol. 2018 Jan 24 PubMed PMID: 29365351; eng. DOI:10.1002/clc.22856.
   Web of Science ®Google Scholar
• Hecht HS. Coronary artery calcium scanning. Past, Present, and Future. 2015;8:579–596.
   Google Scholar